Dec 29, 2021

Featuring perspectives from Prof Simon Chowdhury, including the following topics:

• Introduction (0:00)
• Prostate Cancer Genomic Landscape (1:11)
• Lutetium-177-PSMA-617 (8:45)
• Case: A man in his late 60s with metastatic castration-resistant prostate cancer (mCRPC) and a germline BRCA2 mutation — Zanetta S Lamar, MD (14:33)
• Case: A man in his early 80s with mCRPC and a somatic BRCA2 mutation — Kelly Yap, MD (29:30)
• Case: A man in his late 60s with BRCA1/2 wild-type mCRPC — Jason Hafron, MD (31:37)
• Case: A man in his late 60s with metastatic hormone-sensitive prostate cancer and an ARID1A mutation — Syed F Zafar, MD (35:52)
• Case: A man in his mid-80s with M0 CRPC — Shachar Peles, MD (42:16)
• Case: A man in his early 60s with BRCA1/2 wild-type mCRPC — Sunil Gandhi, MD (51:12)
• Protocol and off-protocol treatment approaches for oligometastatic prostate cancer — David S Morris, MD (54:12)

CME information and select publications